Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

How Schedule M Revised Impacts the Manufacturing of Ayurvedic and Herbal Medicines in India

Posted on February 5, 2025 By digi

How Schedule M Revised Impacts the Manufacturing of Ayurvedic and Herbal Medicines in India

Understanding the Influence of Schedule M Revised on Ayurvedic and Herbal Medicine Manufacturing

Introduction to Schedule M Revised and Ayurvedic Manufacturing

Ayurvedic and herbal medicines form an integral part of India’s pharmaceutical industry, blending traditional practices with modern manufacturing techniques. With the revision of Schedule M under the Drugs and Cosmetics Rules, 1945, there is a renewed focus on implementing Good Manufacturing Practices (GMP) for these products. These updates aim to ensure the quality, safety, and efficacy of Ayurvedic and herbal medicines, aligning them with global standards.

This article explores how Schedule M Revised impacts the manufacturing processes of Ayurvedic and herbal medicines in India, highlighting compliance requirements, industry challenges, and future trends.

Key Requirements of Schedule M Revised for Ayurvedic and Herbal Medicines

1. Facility Design and Infrastructure

Manufacturing facilities for Ayurvedic and herbal medicines must comply with GMP standards to prevent contamination and ensure product consistency. Key requirements include:

  • Segregated areas for raw material storage, processing, and packaging.
  • Proper ventilation, lighting, and environmental controls.
  • Easy-to-clean surfaces made of non-porous materials.

2. Raw Material Sourcing and Quality Control

Raw materials play a critical role in the efficacy of Ayurvedic medicines. Schedule M Revised mandates:

  • Procurement of raw materials from GMP-certified suppliers.
  • Testing for identity, purity, and potency.
  • Documentation of raw material sourcing and quality checks.

3. Process Validation and Standardization

The guidelines emphasize the standardization of manufacturing processes to ensure batch-to-batch consistency. This includes:

  • Validating critical processes such as extraction, blending, and packaging.
  • Establishing standard operating procedures (SOPs) for each stage.
  • Conducting in-process quality checks.

4. Packaging and Labeling

Proper packaging and labeling are essential for maintaining product integrity and informing consumers. Schedule M Revised requires:

  • Use of tamper-proof and moisture-resistant packaging materials.
  • Clear labeling with batch numbers, expiry dates, and dosage instructions.
  • Inclusion of warnings and contraindications.

5. Personnel Training

Employees involved in Ayurvedic medicine manufacturing must be trained in GMP principles and specific herbal processing techniques. Training areas include:

  • Proper handling of raw materials and equipment.
  • Hygiene and sanitation practices.
  • Documentation and record-keeping.

6. Environmental Monitoring

Environmental controls ensure the stability and safety of herbal medicines. Requirements include:

  • Monitoring of temperature and humidity in storage and production areas.
  • Implementation of pest control measures.
  • Regular cleaning and sanitization protocols.

Challenges in Complying with Schedule M Revised for Ayurvedic Manufacturing

1. High Compliance Costs

Upgrading facilities and processes to meet GMP standards can be financially burdensome, especially for small-scale manufacturers.

2. Raw Material Quality Variability

Ensuring the consistency and quality of herbal raw materials is challenging due to natural variability and seasonal availability.

3. Lack of Technical Expertise

Many manufacturers lack the technical knowledge required for process validation and quality control.

4. Documentation Complexity

Maintaining detailed records for sourcing, manufacturing, and quality checks is resource-intensive and requires robust systems.

5. Workforce Training Gaps

Training employees to understand and implement GMP principles specific to Ayurvedic manufacturing is a continuous challenge.

Strategies to Ensure Compliance

1. Invest in Modern Infrastructure

Upgrade manufacturing facilities to meet GMP standards, focusing on cleanroom environments, advanced equipment, and environmental controls.

2. Strengthen Raw Material Sourcing

Collaborate with GMP-certified suppliers and establish strict quality control protocols for raw material testing.

3. Implement Advanced Testing Methods

Use modern analytical techniques such as High-Performance Liquid Chromatography (HPLC) and Gas Chromatography (GC) to verify the quality of herbal ingredients.

4. Develop Comprehensive SOPs

Standardize manufacturing processes with detailed SOPs for each stage, ensuring consistency and compliance.

5. Focus on Employee Training

Conduct regular training sessions on GMP principles, equipment handling, and documentation practices.

6. Leverage Technology

Use digital tools for documentation, inventory management, and environmental monitoring to enhance compliance.

Benefits of Complying with Schedule M Revised

1. Enhanced Product Quality

GMP-compliant processes ensure that Ayurvedic and herbal medicines meet the highest standards of quality and efficacy.

2. Increased Consumer Trust

Compliance builds confidence among consumers and healthcare providers, boosting brand reputation.

3. Simplified Regulatory Approvals

Adhering to Schedule M Revised simplifies the process of obtaining licenses and export approvals.

4. Competitive Advantage

Manufacturers with GMP certification gain a competitive edge in both domestic and international markets.

5. Contribution to Global Standards

Aligning with GMP standards enhances the credibility of Indian Ayurvedic and herbal medicines on a global scale.

Future Trends in Ayurvedic Manufacturing

1. Integration of Advanced Technologies

Automation, IoT, and AI are transforming manufacturing processes, improving efficiency and compliance.

2. Focus on Sustainability

Sustainable sourcing and eco-friendly manufacturing practices are becoming a priority for herbal medicine manufacturers.

3. Expansion of Global Markets

Increasing demand for natural remedies is driving the global expansion of Indian Ayurvedic products.

Conclusion

Schedule M Revised has brought significant improvements to the manufacturing of Ayurvedic and herbal medicines in India, ensuring that they meet global quality standards. While compliance poses challenges, strategic investments in infrastructure, technology, and training can help manufacturers overcome these hurdles.

By adhering to these updated guidelines, the Indian Ayurvedic industry can strengthen its reputation, expand its market reach, and contribute to the global acceptance of traditional medicine.

GMP in India Tags:Biopharmaceutical quality assurance, Corrective and preventive actions GMP, EMA GMP regulations Europe, Emerging markets GMP standards, Environmental control in GMP, FDA GMP guidelines, FDA inspection preparation, Global GMP standards, GMP audits and inspections, GMP compliance Asia, GMP compliance for biopharmaceuticals, GMP compliance North America, GMP compliance tools, GMP documentation best practices, GMP for sterile manufacturing, GMP regulatory approvals, GMP requirements for clinical trials, Health Canada pharmaceutical regulations, KFDA pharmaceutical manufacturing, Lean manufacturing GMP compliance, MHRA pharmaceutical compliance, NMPA GMP guidelines China, Pharmaceutical facility design GMP, Pharmaceutical GMP violations, Pharmaceutical packaging GMP, Pharmaceutical supply chain GMP, PMDA GMP inspections Japan, Risk management in GMP, Schedule M Revised India, Vaccine manufacturing GMP

Post navigation

Previous Post: How Quality Assurance Helps Minimize Risks in GMP Manufacturing
Next Post: Challenges in GMP Compliance for SMEs

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme